Media coverage
16
Media coverage
Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet River Country - News Channel Nebraska Country/Territory United States Date 28/09/24 URL https://rivercountry.newschannelnebraska.com/story/51515386/bristol-myers-squibb-presents-new-data-from-two-trials-demonstrating-sotyktu-deucravacitinib-efficacy-in-both-moderate-to-severe-scalp-psoriasis-and Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet SouthEast - News Channel Nebraska Country/Territory United States Date 28/09/24 URL https://southeast.newschannelnebraska.com/story/51515386/bristol-myers-squibb-presents-new-data-from-two-trials-demonstrating-sotyktu-deucravacitinib-efficacy-in-both-moderate-to-severe-scalp-psoriasis-and Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet Panhandle - News Channel Nebraska Country/Territory United States Date 28/09/24 URL https://panhandle.newschannelnebraska.com/story/51515386/bristol-myers-squibb-presents-new-data-from-two-trials-demonstrating-sotyktu-deucravacitinib-efficacy-in-both-moderate-to-severe-scalp-psoriasis-and Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting; In the Phase 3b/4 PSORIATYK SCALP trial Sotyktu was superior to placebo across Media name/outlet Business Wire Country/Territory United States Date 27/09/24 Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet ADVFN UK Country/Territory United Kingdom Date 27/09/24 URL https://uk.advfn.com/stock-market/NYSE/BMY/share-news/Bristol-Myers-Squibb-Presents-New-Data-from-Two-Tr/94625529 Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet Yahoo! Finance Country/Territory United States Date 27/09/24 URL https://finance.yahoo.com/news/bristol-myers-squibb-presents-data-150600747.html Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet MarketScreener.com Country/Territory United States Date 27/09/24 URL https://www.marketscreener.com/quote/stock/BRISTOL-MYERS-SQUIBB-COMP-11877/news/Bristol-Myers-Squibb-Presents-New-Data-from-Two-Trials-Demonstrating-Sotyktu-deucravacitinib-Effic-47955598/ Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet APNews.com Country/Territory United States Date 27/09/24 URL https://apnews.com/press-release/business-wire/skin-conditions-bristol-myers-squibb-co-medication-2baf2146fc81477995a59046071e9441 Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet ADVFN US Country/Territory United States Date 27/09/24 URL https://www.advfn.com/stock-market/NYSE/BMY/stock-news/94625529/bristol-myers-squibb-presents-new-data-from-two-trials-demonstrating-sotyktu-deu Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet Stockwatch Country/Territory Canada Date 27/09/24 URL www.stockwatch.com/News/Item/U-b20240925005092-U!BMY-20240927/U/BMY Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet Crwe World Country/Territory United States Date 27/09/24 URL crweworld.com/article/news-provided-by-business-wire/3490841/bristol-myers-squibb-presents-new-data-from-two-trials-demonstrating-sotyktu-deucravacitinib-efficacy-in-both-moderate-to-severe-scalp-psoriasis-and-in-a-real-world-setting Persons Mark Lebwohl Title Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate to Severe Scalp Psoriasis and in a Real World Setting Media name/outlet Market News Publishing Country/Territory United States Date 27/09/24 Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet BioSpace Country/Territory United States Date 27/09/24 URL https://www.biospace.com/drug-development/bristol-myers-squibb-presents-new-data-from-two-trials-demonstrating-sotyktu-deucravacitinib-efficacy-in-both-moderate-to-severe-scalp-psoriasis-and-in-a-real-world-setting Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet 96.7 3WZ-FM Country/Territory United States Date 27/09/24 URL https://lifestyle.3wzfm.com/story/51515386/bristol-myers-squibb-presents-new-data-from-two-trials-demonstrating-sotyktu-deucravacitinib-efficacy-in-both-moderate-to-severe-scalp-psoriasis-and Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet Northeast - News Channel Nebraska Country/Territory United States Date 27/09/24 URL https://northeast.newschannelnebraska.com/story/51515386/bristol-myers-squibb-presents-new-data-from-two-trials-demonstrating-sotyktu-deucravacitinib-efficacy-in-both-moderate-to-severe-scalp-psoriasis-and Persons Mark Lebwohl Title Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting Media name/outlet Platte Valley - News Channel Nebraska Country/Territory United States Date 27/09/24 URL https://plattevalley.newschannelnebraska.com/story/51515386/bristol-myers-squibb-presents-new-data-from-two-trials-demonstrating-sotyktu-deucravacitinib-efficacy-in-both-moderate-to-severe-scalp-psoriasis-and Persons Mark Lebwohl